A quick look at reactions across the US to Biden’s Build Back Better bill.

Exploring the potential of vaccines for treatment equity.

The latest issue of The Bioprocess Curator included a lot of interesting news about vaccines. In case you missed it, here's some of the top stories.

Edd Stone of The Technology Partnership outlines current challenges in the cell and gene field - and what we can do about them.

Environmental, social, and governance (ESG) plans should be an integral part of any company that aims to thrive in today’s society.

Anshul Mangal and Tony Khoury of Project Farma weigh in on ways to address the cell and gene therapy skills gap in the US.

How can the NLRP3 inflammasome can be exploited to slow the decline associated with Alzheimer's disease?

Meet Ori Biotech’s Jason Foster. How did he transition to advanced therapy, and why did he end up in the UK?

A drug development journey with origins in the 1950s has finally reached its successful conclusion: a new treatment for lupus.

Four courageous marketer-knights weigh in on what it takes to tilt against the social media windmills of pharma’s digital content kingdom.